About 30 million people around the world have grown legally blind due to retinal diseases. The EPI-RET project has sought for a technical solution for the past twelve years to help these patients.

A retinal prosthesis system can safely, effectively, and reliably restore enough visual function to patients with late-stage retinitis pigmentosa to improve object detection and overall well-being, ...

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...

Neural computation scientists have created a software system that is hoped to improve the function of retinal implants significantly: With the aid of the software, the visual prosthesis "learns" to ...

Retinitis pigmentosa and age-related macular degeneration are two significant causes of severe visual dysfunction. In both, the retinal photoreceptors degenerate, preventing successful conversion of ...

The public markets have proven a rocky path for Second Sight Medical Products ($EYES) since strong initial investor enthusiasm peaked just after its November IPO. But ...

The Intracortical Visual Prosthesis (ICVP), an implant that bypasses the retina and optic nerves to connect directly to the brain's visual cortex, has been successfully surgically implanted in the ...

There are a few notable tech inventions that have changed the medical industry forever. From the use of AI for disease detection to 3D printing biomedical implants and drugs, advances in modern ...

Second Sight, the California-based developer of visual prosthetics and retinal implants, will soon begin a feasibility clinical study to assess its Orion cortical visual prosthesis system in human ...

Berna Gómez of Elche, Spain, wears eyeglasses equipped with a miniature video camera. Gómez spent six months working with researchers to test an experimental visual prosthesis which used an electrode ...

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...

Implanting intraocular lenses (IOLs) after cataract surgery in infants is neither beneficial nor detrimental to long-term visual outcomes, according to a study published in JAMA Ophthalmology. In this ...